Keywords
How to Cite
Abstract
Ushbu maqolada zamonaviy tibbiyotning eng dolzarb muammolaridan biri — klastridial infeksiyalar, xususan Clostridioides difficile keltirib chiqaradigan kasalliklarga qarshi kurashishning yangicha yondashuvlari tahlil qilinadi. An’anaviy antibiotikoterapiyaning samarasizligi va retsidivlar (kasallikning qaytalanishi) soni ortib borayotgani sababli, maqolada fetsal mikrobiota transplantatsiyasi (FMT), immunoterapiya hamda yangi avlod probiotiklarining klinik ahamiyati yoritilgan. Shuningdek, klastridial toksinlarni neytrallashga qaratilgan innovatsion usullar va mikrobiomani qayta tiklash orqali davolash samaradorligini oshirish masalalari ilmiy dalillar asosida koʻrib chiqiladi.
References
1. Surawicz, C. M., et al. (2023). Guidelines for Diagnosis, Treatment, and Prevention of Clostridioides difficile Infections. American Journal of Gastroenterology.
2. Khoruts, A., & Sadowsky, M. J. (2021). Understanding the mechanisms of therapeutic fecal microbiota transplantation. Nature Reviews Gastroenterology & Hepatology.
3. Wilcox, M. H., et al. (2020). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. New England Journal of Medicine.
4. Guery, B., et al. (2024). Innovative therapeutic approaches for Clostridioides difficile infection: Beyond antibiotics. The Lancet Infectious Diseases.
5. Azizov, A. A., & Rahimova, N. S. (2025). Tibbiy mikrobiologiya va ichak disbiozlari: zamonaviy qarashlar. Toshkent, "Tibbiyot" nashriyoti.
6. McDonald, L. C., et al. (2022). Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children. Clinical Infectious Diseases, Oxford Academic.
This work is licensed under a Creative Commons Attribution 4.0 International License.